Market Research Logo
Region: Europe
Category: Pharmaceuticals

Europe Pharmaceuticals

(2737 reports matching your criteria)
  • 2018 Carbapenemase Diagnostics Market: Test Volume and Sales Forecasts by Country--US, Europe, Japan

    ... (France, Germany, Italy, Spain, UK) and Japan. Please note: The delivery time for the electronic version of this report is between 1-3 business days to allow the preparation of an updated version prior to dispatch. Read More

  • Europe Pharmaceuticals & Healthcare Q4 2018

    ... to region-specific trends. Themore developed Western markets will continue to be favoured by innovative drugmakers due to stronger regulatory oversight andgreater purchasing power, although growth in these markets will be suppressed by aggressive cost-containment. Revenue ... Read More

  • France Pharmaceuticals & Healthcare Q1 2019

    ... recent commitments towards accelerating marketauthorisation of innovative medicines, as well as optimising market access and promoting innovation and clinical research,anticipate an effort to transform France into a highly attractive market for drugmakers and investors, reversing ... Read More

  • Germany Pharmaceuticals & Healthcare Q4 2018

    ... to services, will continue tosupport this potential. However, we do caution that market access is now challenging, as authorities use a range of cost-containment measures and downward price pressures as a means of controlling state ... Read More

  • Poland Pharmaceuticals & Healthcare Q4 2018

    ... future of the Fund; however, the outlook for the pharmaceutical market andhealthcare sector remain positive. Continued state healthcare funding growth and consumer-led economic growth will provide aboost to market expenditure, maintaining the country's regional outperformance. Read More

  • Austria Pharmaceuticals & Healthcare Q4 2018

    ... sizecompared to its EU partners. However, like its eurozone neighbours, we believe Austria's pharmaceutical spending will be subduedover the medium term, as states scramble to contain rising pharmaceutical expenditure in line with increasing healthcare demands. Read More

  • Slovakia Pharmaceuticals & Healthcare Q4 2018

    ... be driven bygovernment plans to improving access to health services with hospital reforms and diseases prevention programs. However, thegovernment’s implementation of cost-containment measures and the growing use of generic medicines will limit opportunities forinnovative drugmakers. Read More

  • 2018 Germany HIV/AIDS Diagnostics Market Shares and Segment Forecasts: HIV 1/2, Combo, Ag, NAT, Western Blot

    ... confirmatory assays performed in the following market segments: - Hospitals - Commercial/Private Labs- Blood Banks The DataPack also provides sales and market share estimates for major suppliers of AIDS tests, including Abbott, Biotest, bioMerieux, Bio-Rad, ... Read More

  • 2018 Italy HIV/AIDS Diagnostics Market Shares and Segment Forecasts: HIV 1/2, Combo, Ag, NAT, Western Blot

    ... confirmatory assays performed in the following market segments: - Hospitals - Commercial/Private Labs- Blood Banks The DataPack also provides sales and market share estimates for major suppliers of AIDS tests, including Abbott, bioMerieux, Bio-Rad, DiaSorin, ... Read More

  • 2018 Spain HIV/AIDS Diagnostics Market Shares and Segment Forecasts: HIV 1/2, Combo, Ag, NAT, Western Blot

    ... confirmatory assays performed in the following market segments: - Hospitals - Commercial/Private Labs- Blood Banks The DataPack also provides sales and market share estimates for major suppliers of AIDS tests, including Abbott, Biokit, bioMerieux, Bio-Rad, ... Read More

  • 2018 UK HIV/AIDS Diagnostics Market Shares and Segment Forecasts: HIV 1/2, Combo, Ag, NAT, Western Blot

    ... other confirmatory assays performed in the following market segments: - Hospitals - Commercial/Private Labs- Blood Banks- Public Health Labs - Physician Offices The DataPack also provides sales and market share estimates for major suppliers of ... Read More

  • 2018 France HIV/AIDS Diagnostics Market Shares and Segment Forecasts: HIV 1/2, Combo, Ag, NAT, Western Blot

    ... confirmatory assays performed in the following market segments: - Hospitals - Commercial/Private Labs- Blood Banks The DataPack also provides sales and market share estimates for major suppliers of AIDS tests, including Abbott, Biotest, bioMerieux, Bio-Rad, ... Read More

  • France Respiratory Measurement Devices Market Outlook to 2025

    ... value, in millions of US dollars, volume (in units) and average prices (USD) within market segments - Pulse Oximeter Systems, Capnographs, Spirometers and Peak Flow Meters. The report also provides company shares and distribution shares ... Read More

  • United Kingdom Respiratory Measurement Devices Market Outlook to 2025

    ... The report provides value, in millions of US dollars, volume (in units) and average prices (USD) within market segments - Pulse Oximeter Systems, Capnographs, Spirometers and Peak Flow Meters. The report also provides company shares ... Read More

  • Italy Respiratory Measurement Devices Market Outlook to 2025

    ... value, in millions of US dollars, volume (in units) and average prices (USD) within market segments - Pulse Oximeter Systems, Capnographs, Spirometers and Peak Flow Meters. The report also provides company shares and distribution shares ... Read More

  • Spain Respiratory Measurement Devices Market Outlook to 2025

    ... value, in millions of US dollars, volume (in units) and average prices (USD) within market segments - Pulse Oximeter Systems, Capnographs, Spirometers and Peak Flow Meters. The report also provides company shares and distribution shares ... Read More

  • Portugal Pharmaceuticals & Healthcare Q4 2018

    ... increasingly important role in the healthcaresystem. Despite rising public health spending, the public hospital sector will continue to face challenges after several years ofdeterioration and management concerns. Although commercial opportunities for drugmakers will significantly improve ... Read More

  • Slovenia Pharmaceuticals & Healthcare Q4 2018

    ... the background of economic growth and risingrevenues, the Slovene government is poised to slightly increase public healthcare spending over the coming quarters. However,over the long term, the health system financial sustainability will remain dependent upon ... Read More

  • Belarus Pharmaceuticals & Healthcare Q4 2018

    ... on the use of generic products, andthe encouragement of domestic industry expansion, which discourages use of novel products. The placement of high-valuepatented medicines on the market is disadvantaged by corruption, elevated political risks, limited private ... Read More

  • Hungary Pharmaceuticals & Healthcare Q4 2018

    ... averages, placing pressure on thepublic healthcare budget. The burden of medicine costs is likely to continue to shift onto household, reducing their affordability andtherefore dampening medicine demand. Unless the Hungarian government makes radical changes to ... Read More

  • Bulgaria Pharmaceuticals & Healthcare Q4 2018

    ... as regional partners, and an overhaul of its drug reimbursement system will formthe core of government reforms to raise healthcare standards. Despite this, the investment climate formultinational pharmaceutical firms is expected to remain challenging with ... Read More

  • Italy Pharmaceuticals & Healthcare Q4 2018

    ... of new innovative therapies. Although this will translate into renewedcommercial opportunities for drugmakers, operating conditions will remain challenging due to cost-control measures targetingpharmaceutical and healthcare spending. In fact, despite the new government’s populist leaning, fiscal ... Read More

  • Netherlands Pharmaceuticals & Healthcare Q4 2018

    ... The government and insurers will continue to contain risinghealthcare cost through various cost-cutting measures and pro-generic dug policies. Nevertheless, the country’s strong researchand development infrastructure and aging population make it an attractive destination for innovative ... Read More

  • Serbia Pharmaceuticals & Healthcare Q4 2018

    ... and a growing government commitment to improve the healthcaresystem. However, the market will continue to be dominated by lower-value generic medicines, with opportunities for innovativedrugmakers limited by Serbia’s weak regulatory environment and low purchasing power. Read More

  • Spain Airway and Anesthesia Procedures Outlook to 2025

    ... procedure volumes within market segments - Airway Management Procedures, Anesthesia Circuit Procedures, Anesthesia Mask Procedures, Breathing Bag Procedures, Breathing Filter Procedures, Intubation Accessory Procedures, Laryngoscope Blade Procedures and Laryngoscope Handle Procedures. The data in the ... Read More

< prev 1 3 4 5 6 7 8 9 10